These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 5354750

  • 1. [Blastomogenesis in rats in the presence of the combined action of N-2-fluorenylacetamide and N-nitrosodimethylamine].
    Likhachev AIa.
    Vopr Onkol; 1969; 15(9):65-9. PubMed ID: 5354750
    [No Abstract] [Full Text] [Related]

  • 2. Influence of 3-methylcholanthrene on liver carcinogenesis in rats ingesting DL-ethionine, 3'-methyl-4-dimethylaminoazobenzene, and N-2-fluorenylacetamide.
    Marugami M, Ito N, Konishi Y, Hiasa Y, Farber E.
    Cancer Res; 1967 Nov; 27(11):2011-9. PubMed ID: 4965303
    [No Abstract] [Full Text] [Related]

  • 3. Effects of trypan blue on hepatocarcinogenesis in rats given ethionine or N-2-fluorenylacetamide.
    Ito N, Farber E.
    J Natl Cancer Inst; 1966 Dec; 37(6):775-85. PubMed ID: 4289069
    [No Abstract] [Full Text] [Related]

  • 4. The cellular analysis of liver carcinogenesis: ultrastructural alterations within hyperplastic liver nodules induced by 2-fluorenylacetamide.
    Merkow LP, Epstein SM, Caito BJ, Bartus B.
    Cancer Res; 1967 Sep; 27(9):1712-21. PubMed ID: 6051282
    [No Abstract] [Full Text] [Related]

  • 5. Cellular analysis of liver carcinogenesis: the induction of large hyperplastic nodules in the liver with 2-fluorenylacetamide or ethionine and some aspects of their morphology and glycogen metabolism.
    Epstein S, Ito N, Merkow L, Farber E.
    Cancer Res; 1967 Sep; 27(9):1702-11. PubMed ID: 4293077
    [No Abstract] [Full Text] [Related]

  • 6. Early elevation of alpha 1-fetoprotein in N-2-fluorenylacetamide hepatocarcinogenesis.
    Becker FF, Sell S.
    Cancer Res; 1974 Oct; 34(10):2489-94. PubMed ID: 4412886
    [No Abstract] [Full Text] [Related]

  • 7. The carcinogenicity of the o-methoxy derivatives of N-2-fluorenylacetamide and of related compounds in the rat.
    Gutmann HR, Galitski SB, Foley WA.
    Cancer Res; 1968 Feb; 28(2):234-44. PubMed ID: 5641517
    [No Abstract] [Full Text] [Related]

  • 8. [Blastomogenesis in mice following combined trans-placental and post-natal effects of NDEA and NMM].
    Likhachev AI.
    Vopr Onkol; 1972 Feb; 18(1):71-6. PubMed ID: 5017178
    [No Abstract] [Full Text] [Related]

  • 9. Isozyme patterns of pyruvate kinase in various primary liver tumors induced during the process of hepatocarcinogenesis.
    Yanagi S, Makiura S, Arai M, Matsumura K, Hirao K.
    Cancer Res; 1974 Sep; 34(9):2283-9. PubMed ID: 4367288
    [No Abstract] [Full Text] [Related]

  • 10. Enhancing effect of chemicals on production of hyperplastic liver nodules induced by n-2-fluorenylacetamide in hepatectomized rats.
    Ito N, Tatematsu M, Hirose M, Nakanishi K, Murasaki G.
    Gan; 1978 Feb; 69(1):143-4. PubMed ID: 416986
    [No Abstract] [Full Text] [Related]

  • 11. Combined enzyme histochemical and radioautographic studies on areas of hyperplasia in the liver of rats fed N-2-fluorenylacetamide.
    Kitagawa T, Sugano H.
    Cancer Res; 1973 Nov; 33(11):2993-3001. PubMed ID: 4355988
    [No Abstract] [Full Text] [Related]

  • 12. Systematic effect of testosterone on rat liver tumor induction by N-2-fluorenylacetamide.
    Toh YC.
    J Natl Cancer Inst; 1972 Jan; 48(1):113-8. PubMed ID: 4652367
    [No Abstract] [Full Text] [Related]

  • 13. Influence of orotic acid on liver tumorigenesis in rats ingesting ethionine, N-2-fluorenylacetamide, and 3'-methyl-dimethylaminoazobenzene.
    Sidransky H, Verney E.
    J Natl Cancer Inst; 1970 May; 44(5):1201-15. PubMed ID: 5514477
    [No Abstract] [Full Text] [Related]

  • 14. [Experimental investigations in "syncarcinogenesis". VI. Addition of minimum doses of 4 different liver carcinogens in rats in liver cancer development].
    Schmähl D.
    Z Krebsforsch; 1970 May; 74(4):457-66. PubMed ID: 4253317
    [No Abstract] [Full Text] [Related]

  • 15. Induction of transplantable liver tumors in DBF mice after oral administration of n,n'-2,7-fluorenylenebisacetamide.
    Takayama S.
    J Natl Cancer Inst; 1968 Mar; 40(3):629-41. PubMed ID: 5644205
    [No Abstract] [Full Text] [Related]

  • 16. The cellular analysis of liver carcinogenesis. VI. Growth and ultrastructural characteristics of n-2-fluorenylacetamide hyperplastic liver nodule cells grown in vitro.
    Slifkin M, Merkow LP, Epstein SM, Pardo M.
    Arch Pathol; 1972 Jul; 94(1):1-10. PubMed ID: 4338214
    [No Abstract] [Full Text] [Related]

  • 17. [Synergism between orally active carcinogens. IV. Results of simultaneous feeding of 4 carcinogens in rats].
    Deichmann WB, Keplinger ML, Glass EM.
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967 Jul; 257(1):12. PubMed ID: 4231827
    [No Abstract] [Full Text] [Related]

  • 18. Effect of acetanilide and p-hydroxyacetanilide on the carcinogenicity of N-2-fluorenylacetamide and N-hydroxy-N-2-fluorenylacetamide in mice, hamsters, and female rats.
    Weisburger JH, Weisburger EK, Madison RM, Wenk ML, Klein DS.
    J Natl Cancer Inst; 1973 Jul; 51(1):235-40. PubMed ID: 4720874
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.